Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wan, Xiang  [Clear All Filters]
2023
Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, et al. The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases. Am J Hematol. 2023.
Tu M, Huang A, Ning L, Tang B, Zhang C, Sun G, Wan X, Song K, Yao W, Qiang P, et al. A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation. Stem Cell Res Ther. 2023;14(1):304.
2022
Li N, Sun G, Zhu L, Ding K, Liu H, Zhu X, Tang B, Yao W, Wan X, Geng L, et al. Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation. J Immunol Res. 2022;2022:6285510.
2021
Zhang X, Liu H, Zheng C, Tang B, Zhu X, Wan X, Tong J, Yao W, Song K, Sun Z. Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin. Acta Haematol. 2021:1-11.
2020
Yao W, Chu X, Fang X, Zhu X, Tang B, Wan X, Geng L, Tong J, Song K, Zhang X, et al. Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission. J Clin Pharm Ther. 2020.